Skip to playerSkip to main content
  • 6 years ago
In a big boost to India's nationwide Covid-19 vaccination drive, Bharat Biotech announced that the interim analysis of Covaxin show the vaccine demonstrates 81 per cent interim efficacy.

Category

🗞
News

Recommended